Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
Titel:
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
Auteur:
Dudek, Arkadiusz Z. Liu, Li C. Fischer, James H. Wiley, Elizabeth L. Sachdev, Jasgit C. Bleeker, Jonathan Hurley, Randolph W. Tonetti, Debra A. Thatcher, Gregory R. J. Venuti, Robert P. O’Regan, Ruth M.